Published in BMC Clin Pathol on July 14, 2014
Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay. PLoS One (2015) 1.39
Evaluation of Basal Serum or Plasma Cortisol Concentrations for the Diagnosis of Hypoadrenocorticism in Dogs. J Vet Intern Med (2016) 0.79
Adrenal and thyroid function in the fetus and preterm infant. Korean J Pediatr (2014) 0.77
Molecular similarity: a key technique in molecular informatics. Org Biomol Chem (2004) 2.14
In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol (2007) 1.78
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol (2012) 1.65
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone. Ann Clin Biochem (2011) 1.57
Interferences in immunoassay--still a threat. Clin Chem (2000) 1.50
Steroid hormone analysis by tandem mass spectrometry. Clin Chem (2009) 1.47
Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol (2010) 1.46
Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol (2010) 1.33
Virtual screening in drug discovery -- a computational perspective. Curr Protein Pept Sci (2007) 1.32
The importance of discerning shape in molecular pharmacology. Trends Pharmacol Sci (2009) 1.17
Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab (1989) 1.13
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. BMC Emerg Med (2009) 1.12
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Cancer Res (1992) 1.11
Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem (2006) 1.04
Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev (2003) 1.02
Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol (2002) 1.00
Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta (2007) 0.97
The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther (1999) 0.97
Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. J Clin Endocrinol Metab (2013) 0.97
Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol (2004) 0.96
Immunoassay of estradiol: unanticipated suppression by unconjugated estriol. Clin Chem (2004) 0.96
Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. J Mol Biol (2002) 0.93
Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect. Clin Chim Acta (2007) 0.93
Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem (2000) 0.92
17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia. Eur J Pediatr (1980) 0.89
Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol (2009) 0.89
Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab (2006) 0.89
Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab (2002) 0.89
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther (1998) 0.87
Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.86
Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol (1989) 0.86
Performance characteristics of five automated serum cortisol immunoassays. Clin Biochem (2004) 0.85
Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains. J Biol Chem (2002) 0.85
Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays. Clin Toxicol (Phila) (2013) 0.85
Measurement of glucocorticoids in biological fluids. Methods Mol Biol (2006) 0.84
Chemoinformatic methods for predicting interference in drug of abuse/toxicology immunoassays. Clin Chem (2009) 0.83
Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men. J Clin Endocrinol Metab (2005) 0.83
Interferences in hormone immunoassays. Clin Lab Med (2004) 0.83
Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays. Ther Drug Monit (2009) 0.82
Simultaneous determination of spironolactone and its metabolites in human plasma. J Pharm Biomed Anal (1996) 0.82
Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology (2005) 0.82
The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther (2004) 0.81
Rapid liquid-chromatographic method for simultaneous determination of plasma prednisone, prednisolone, and cortisol in pediatric renal-transplant recipients. Clin Chem (1991) 0.81
Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Ann Clin Biochem (2007) 0.80
Pregnanolone isomers, pregnenolone and their polar conjugates around parturition. Physiol Res (2003) 0.80
Biochemistry and physiology of anabolic androgenic steroids doping. Mini Rev Med Chem (2011) 0.80
Measurement of androgens. Methods Mol Biol (2006) 0.80
Detecting the administration of endogenous anabolic androgenic steroids. Handb Exp Pharmacol (2010) 0.80
Pharmacokinetics and metabolism of formestane in breast cancer patients. J Steroid Biochem Mol Biol (2001) 0.79
Preliminary study for simultaneous detection and quantification of androgenic anabolic steroids using ELISA and pattern recognition techniques. Analyst (2011) 0.79
Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration. Clin Chim Acta (2012) 0.79
Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Ann Clin Biochem (2006) 0.78
Specificity improvement of a recombinant anti-testosterone Fab fragment by CDRIII mutagenesis and phage display selection. Protein Eng (1998) 0.78
Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones. J Endocrinol Invest (2011) 0.78
Stable isotope methodology in the pharmacokinetic studies of androgenic steroids in humans. Steroids (1990) 0.78
Structural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound forms. J Biol Chem (2001) 0.77
Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Altern Med Rev (1999) 0.77
Interference of the antihormone RU486 in the determination of testosterone and estradiol by enzyme-immunoassay. Clin Chim Acta (1998) 0.77
Comparison of progesterone concentration determination by 12 non-isotopic immunoassays and gas chromatography/mass spectrometry in 99 human serum samples. J Steroid Biochem Mol Biol (2001) 0.76
Improved bioavailability and clinical response in patients with chronic liver disease following the administration of a spironolactone: beta-cyclodextrin complex. Br J Clin Pharmacol (1997) 0.76
Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women. Cancer Chemother Pharmacol (1998) 0.76
Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects. Clin Chem Lab Med (1999) 0.76
Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. J Vet Pharmacol Ther (2007) 0.76